In what it describes as an Australian first, Bupa has announced a new program to provide health insurance customers with free pharmacogenomic testing kits until the end of 2025, giving individuals greater insight into how their genetics influence responses to more than 100 commonly prescribed medications.
Bupa launches free pharmacogenomics program to support safer, more effective medicine use
September 24, 2025 BioPharmaOther Health
Latest Video
New Stories
-
Nasal adrenaline to be added to the PBS for people at risk of anaphylaxis
June 30, 2026 - - Latest News -
When it comes to negotiating with government, trust actions and not words
June 30, 2026 - - Latest News -
Neuren partner secures critical European backing for Rett syndrome therapy
June 30, 2026 - - Australian Biotech -
Disappointment for CSL as Europe recommends reversing approval of therapy
June 30, 2026 - - BioPharma -
Ipsen therapy approved in Australia for rare genetic disorder
June 30, 2026 - - Latest News -
New MSD vaccine listed on national program with expanded eligibility
June 30, 2026 - - Latest News -
A comment that highlights how complexity is making the challenge more challenging
June 29, 2026 - - Latest News


